Naproxen Supplier-Buyer Network — Trade Flow Analysis

Name: Naproxen Supplier-Buyer Trade Network Dataset — 192+ Indian Exporters, 12+ Importers, 76+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Naproxen supplier network, Naproxen buyers, pharmaceutical export India, Naproxen trade data

TransData Nexus

Naproxen

India Pharmaceutical Trade Intelligence

$133.8M192 Suppliers76 CountriesHS 30049069

ExportsIndia → UNITED STATES42.1%India → CANADA21.1%

ImportsUNITED STATES → India$391.7K GERMANY → India$185.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Who Supplies Naproxen? Top Manufacturers & Buyers 2026 — MYLAN LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the first-largest Naproxen exporter from India, with a market share of 16.5% and a total export value of $22.1M across 55 shipments. Their average shipment value of $402.6K is above the market average of $39.2K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN PHARMACEUTICALS ULC, is the dominant customer, accounting for 90.7% of this supplier's tracked business. Top customers include:

• MYLAN PHARMACEUTICALS ULC, — $20.1M across 50 shipments (90.7% of this supplier's total exports)

• MYLAN PHARMACEUTICALS ULC, — $1.3M across 3 shipments (5.7% of this supplier's total exports)

• MYLAN PHARMACEUTICALS ULC, — $554.8K across 1 shipments (2.5% of this supplier's total exports)

• MYLAN HUNGARY KFT, — $121.8K across 0 shipments (0.5% of this supplier's total exports)

• MYLAN IRELAND C/O AL — $120.2K across 0 shipments (0.5% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $402.6K is 927% above the market average of $39.2K, consistent with large-order contracts or value-added formulations.

2UNICHEM LABORATORIES LIMITED

UNICHEM LABORATORIES LIMITED is the second-largest Naproxen exporter from India, with a market share of 10.3% and a total export value of $13.8M across 276 shipments. Their average shipment value of $50.1K is above the market average of $39.2K, suggesting premium or bulk contract pricing.

UNICHEM LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• KRKA D.D., NOVO MESTO — $4.7M across 95 shipments (34.3% of this supplier's total exports)

• KRKA D.D., NOVO MESTO — $4.6M across 92 shipments (33.2% of this supplier's total exports)

• KRKA D.D., NOVO MESTO — $3.1M across 61 shipments (22.2% of this supplier's total exports)

• KRKA, D,D, NOVO MESTO — $753.8K across 15 shipments (5.5% of this supplier's total exports)

• KRKA D.D., NOVO MESTO — $665.5K across 13 shipments (4.8% of this supplier's total exports)

Key Insight: UNICHEM LABORATORIES LIMITED's per-shipment value of $50.1K is 28% above the market average of $39.2K, consistent with large-order contracts or value-added formulations.

3AMNEAL PHARMACEUTICALS PRIVATE LIMITED

AMNEAL PHARMACEUTICALS PRIVATE LIMITED is the third-largest Naproxen exporter from India, with a market share of 6.8% and a total export value of $9.1M across 119 shipments. Their average shipment value of $76.8K is above the market average of $39.2K, suggesting premium or bulk contract pricing.

AMNEAL PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. AMNEAL PHARMACEUTICALS LLC is the dominant customer, accounting for 57.8% of this supplier's tracked business. Top customers include:

• AMNEAL PHARMACEUTICALS LLC — $5.3M across 69 shipments (57.8% of this supplier's total exports)

• AMNEAL PHARMACEUTICALS LLC — $1.7M across 22 shipments (18.8% of this supplier's total exports)

• AMNEAL PHARMACEUTICALS LLC — $831.1K across 11 shipments (9.1% of this supplier's total exports)

• AMNEAL PHARMACEUTICALS LLC — $658.3K across 9 shipments (7.2% of this supplier's total exports)

• AMNEAL PHARMACEUTICALS LLC — $647.8K across 8 shipments (7.1% of this supplier's total exports)

Key Insight: AMNEAL PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $76.8K is 96% above the market average of $39.2K, consistent with large-order contracts or value-added formulations.

4GLENMARK PHARMACEUTICALS LIMITED

GLENMARK PHARMACEUTICALS LIMITED is the fourth-largest Naproxen exporter from India, with a market share of 5.0% and a total export value of $6.7M across 303 shipments. Their average shipment value of $22.0K is below the market average of $39.2K, reflecting a high-volume, competitive pricing strategy.

GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. GLENMARK PHARMACEUTICALS INC USA is the dominant customer, accounting for 53.7% of this supplier's tracked business. Top customers include:

• GLENMARK PHARMACEUTICALS INC USA — $3.6M across 163 shipments (53.7% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $1.2M across 53 shipments (17.5% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $846.3K across 38 shipments (12.7% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $753.6K across 34 shipments (11.3% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $322.3K across 15 shipments (4.8% of this supplier's total exports)

Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (303 shipments) at a per-shipment value of $22.0K, indicating a broad distribution network with many smaller, regular orders.

5GRANULES INDIA LIMITED

GRANULES INDIA LIMITED is the fifth-largest Naproxen exporter from India, with a market share of 4.7% and a total export value of $6.2M across 191 shipments. Their average shipment value of $32.6K is below the market average of $39.2K, reflecting a high-volume, competitive pricing strategy.

GRANULES INDIA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• GRANULES PHARMACEUTICALS, INC. — $2.0M across 63 shipments (32.7% of this supplier's total exports)

• GRANULES PHARMACEUTICALS, INC. — $1.3M across 41 shipments (21.4% of this supplier's total exports)

• GRANULES CONSUMER HE — $984.0K across 30 shipments (15.8% of this supplier's total exports)

• PHARMASCIENCE INC — $961.8K across 30 shipments (15.5% of this supplier's total exports)

• GRANULES PHARMACEUTICALS, INC. — $908.9K across 28 shipments (14.6% of this supplier's total exports)

Key Insight: GRANULES INDIA LIMITED operates with high shipment frequency (191 shipments) at a per-shipment value of $32.6K, indicating a broad distribution network with many smaller, regular orders.

6DR.REDDY'S LABORATORIES LTD

DR.REDDY'S LABORATORIES LTD is the fifth-largest Naproxen exporter from India, with a market share of 2.3% and a total export value of $3.1M across 81 shipments. Their average shipment value of $38.0K is below the market average of $39.2K, reflecting a high-volume, competitive pricing strategy.

DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• WESTROCK — $1.5M across 39 shipments (47.9% of this supplier's total exports)

• DR.REDDYS LABORATORI — $589.5K across 16 shipments (19.1% of this supplier's total exports)

• DR.REDDYS LABORATORI — $513.8K across 14 shipments (16.7% of this supplier's total exports)

• DR.REDDYS LABORATORI — $298.5K across 8 shipments (9.7% of this supplier's total exports)

• DR.REDDYS LABORATORI — $202.0K across 5 shipments (6.6% of this supplier's total exports)

Key Insight: DR.REDDY'S LABORATORIES LTD operates with high shipment frequency (81 shipments) at a per-shipment value of $38.0K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Naproxen imports from India, with a total trade value of $56.4M across 642 shipments — representing a 42.1% share of all Naproxen exports. The average shipment value of $87.8K is above the global average of $39.2K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.

Named Naproxen importers in United States: GLENMARK PHARMACEUTICALS INC., USA is the largest buyer, accounting for 19.5% ($11.0M) of this market's total imports.

• GLENMARK PHARMACEUTICALS INC., USA — $11.0M (19.5% of United States's total)

• AMNEAL PHARMACEUTICALS, LLC (KY) — $8.7M (15.5% of United States's total)

• DR REDDYS LABORATORIES INC — $4.9M (8.7% of United States's total)

Key Insight: United States's per-shipment average of $87.8K (124% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Naproxen imports from India.

Primary Market

Secondary Market

2Canada

Canada ranks as the second-largest destination for Naproxen imports from India, with a total trade value of $28.3M across 53 shipments — representing a 21.1% share of all Naproxen exports. The average shipment value of $533.7K is above the global average of $39.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Naproxen importers in Canada: MYLAN PHARMACEUTICALS ULC, is the largest buyer, accounting for 71.7% ($20.3M) of this market's total imports.

• MYLAN PHARMACEUTICALS ULC, — $20.3M (71.7% of Canada's total)

• PHARMASCIENCE INC — $1.9M (6.7% of Canada's total)

• APOTEX INC — $1.7M (5.9% of Canada's total)

Key Insight: Canada's per-shipment average of $533.7K (1262% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Naproxen imports from India.

Primary Market

Secondary Market

3Slovenia

Slovenia ranks as the third-largest destination for Naproxen imports from India, with a total trade value of $21.7M across 254 shipments — representing a 16.2% share of all Naproxen exports. The average shipment value of $85.5K is above the global average of $39.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Naproxen importers in Slovenia: KRKA D.D., NOVO MESTO is the largest buyer, accounting for 40.1% ($8.7M) of this market's total imports.

• KRKA D.D., NOVO MESTO — $8.7M (40.1% of Slovenia's total)

• KRKA, D.D., NOVO MESTO — $5.0M (23.0% of Slovenia's total)

• KRKA D D NOVO MESTO — $4.6M (21.1% of Slovenia's total)

Key Insight: Slovenia's per-shipment average of $85.5K (118% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Slovenia is a key market for Naproxen imports from India.

Primary Market

Secondary Market

4Malta

Malta ranks as the fourth-largest destination for Naproxen imports from India, with a total trade value of $8.6M across 291 shipments — representing a 6.5% share of all Naproxen exports. The average shipment value of $29.7K is below the global average of $39.2K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.

Named Naproxen importers in Malta: APL SWIFT SERVICES (MALTA) LTD., is the largest buyer, accounting for 59.7% ($5.2M) of this market's total imports.

• APL SWIFT SERVICES (MALTA) LTD., — $5.2M (59.7% of Malta's total)

Key Insight: Malta receives frequent, smaller shipments of Naproxen — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Malta is a key market for Naproxen imports from India.

Primary Market

Secondary Market

5Spain

Spain ranks as the fifth-largest destination for Naproxen imports from India, with a total trade value of $6.0M across 156 shipments — representing a 4.5% share of all Naproxen exports. The average shipment value of $38.7K is below the global average of $39.2K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.

Named Naproxen importers in Spain: ATNAHS PHARMA UK LIMITED is the largest buyer, accounting for 85.2% ($5.1M) of this market's total imports.

• ATNAHS PHARMA UK LIMITED — $5.1M (85.2% of Spain's total)

Key Insight: Spain receives frequent, smaller shipments of Naproxen — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Spain is a key market for Naproxen imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Naproxen.
2.Flow Mapping: 192 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,414 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 76 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,414 Verified Shipments

192 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Naproxen

Naproxen

Who Supplies Naproxen? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Naproxen? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Naproxen Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MYLAN LABORATORIES LIMITED

2UNICHEM LABORATORIES LIMITED

3AMNEAL PHARMACEUTICALS PRIVATE LIMITED

4GLENMARK PHARMACEUTICALS LIMITED

5GRANULES INDIA LIMITED

6DR.REDDY'S LABORATORIES LTD

From Indian Factories to Global Pharmacies — How Naproxen Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Naproxen Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Canada

3Slovenia

4Malta

5Spain

People Also Ask — Naproxen Supplier & Trade Network

Naproxen Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology